T. Kuiken, B. Riteau, R. A. Fouchier, and G. F. Rimmelzwaan, Pathogenesis of influenza virus infections: The good, the bad and the ugly, Curr. Opin. Virol, vol.2, pp.276-286, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01595054

A. S. Lipatov, E. A. Govorkova, R. J. Webby, H. Ozaki, M. Peiris et al., Influenza: Emergence and control, J. Virol, vol.78, pp.8951-8959, 2004.

F. Berri, V. B. Le, M. Jandrot-perrus, B. Lina, and B. Riteau, Switch from protective to adverse inflammation during influenza: Viral determinants and hemostasis are caught as culprits, Cell. Mol. Life Sci. CMLS, vol.71, pp.885-898, 2014.

X. Xiong, J. W. Mccauley, and D. A. Steinhauer, Receptor binding properties of the influenza virus hemagglutinin as a determinant of host range, Curr. Top. Microb. Immunol, vol.385, pp.63-91, 2014.

S. Wilks, M. De-graaf, D. J. Smith, and D. F. Burke, A review of influenza haemagglutinin receptor binding as it relates to pandemic properties, vol.30, pp.4369-4376, 2012.

X. Sun and G. R. Whittaker, Entry of influenza virus, Adv. Exp. Med. Biol, vol.790, pp.72-82, 2013.

E. C. Hutchinson and E. Fodor, Transport of the influenza virus genome from nucleus to nucleus, vol.5, pp.2424-2446, 2013.

T. Samji, Influenza A: Understanding the viral life cycle, Yale J. Biol. Med, vol.82, pp.153-159, 2009.

D. P. Nayak, R. A. Balogun, H. Yamada, Z. H. Zhou, and S. Barman, Influenza virus morphogenesis and budding, Virus Res, vol.143, pp.147-161, 2009.

F. Lebouder, E. Morello, G. F. Rimmelzwaan, F. Bosse, C. Pechoux et al., Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin, J. Virol, vol.82, pp.6820-6828, 2008.

F. Berri, G. Haffar, V. B. Le, A. Sadewasser, K. Paki et al., Annexin V incorporated into influenza virus particles inhibits gamma interferon signaling and promotes viral replication, J. Virol, vol.88, pp.11215-11228, 2014.

S. Tcherniuk, N. Cenac, M. Comte, J. Frouard, E. Errazuriz-cerda et al., Formyl Peptide Receptor 2 Plays a Deleterious Role During Influenza A Virus Infections, J. Infect. Dis, vol.214, pp.237-247, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01478131

M. L. Shaw, K. L. Stone, C. M. Colangelo, E. E. Gulcicek, and P. Palese, Cellular proteins in influenza virus particles, PLoS Pathog, 2008.

N. Courtin, A. F. Fotso, P. Fautrad, F. Mas, M. C. Alessi et al., Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses, Antivir. Res, vol.143, pp.252-261, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01755130

H. Marjuki, A. Gornitzky, B. M. Marathe, N. A. Ilyushina, J. R. Aldridge et al., Influenza A virus-induced early activation of ERK and PI3K mediates V-ATPase-dependent intracellular pH change required for fusion, Cell. Microbiol, vol.13, pp.587-601, 2011.

S. Pleschka, T. Wolff, C. Ehrhardt, G. Hobom, O. Planz et al., Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade, Nat. Cell Boil, vol.3, pp.301-305, 2001.

Y. S. Bae, H. Y. Lee, E. J. Jo, J. I. Kim, H. K. Kang et al., Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling, J. Immunol, vol.173, pp.607-614, 2004.

A. Portela and P. Digard, The influenza virus nucleoprotein: A multifunctional RNA-binding protein pivotal to virus replication, J. Gen. Virol, vol.83, issue.4, pp.723-734, 2002.

A. Casadevall, Antibody-based therapies for emerging infectious diseases, Emerg. Infect. Dis, vol.2, pp.200-208, 1996.

L. V. Norling, J. Dalli, R. J. Flower, C. N. Serhan, and M. Perretti, Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: Receptor-dependent actions, Arterioscler. Thromb. Vasc. Biol, vol.32, 1970.

C. De-santo, R. Arscott, S. Booth, I. Karydis, M. Jones et al., Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A, Nat. Immunol, vol.11, pp.1039-1046, 2010.

M. C. Alessi, N. Cenac, M. Si-tahar, and B. Riteau, FPR2: A Novel Promising Target for the Treatment of Influenza. Front, 1719.
URL : https://hal.archives-ouvertes.fr/hal-01744140

S. Arora, W. Lim, P. Bist, R. Perumalsamy, H. M. Lukman et al., Influenza A virus enhances its propagation through the modulation of Annexin-A1 dependent endosomal trafficking and apoptosis, Cell Death Differ, vol.23, pp.1243-1256, 2016.

U. Rescher and V. Gerke, Annexins-Unique membrane binding proteins with diverse functions, J. Cell Sci, vol.13, pp.2631-2639, 2004.

M. Hoque, C. Rentero, R. Cairns, F. Tebar, C. Enrich et al., Annexins-scaffolds modulating PKC localization and signaling, Cell. Signal, vol.26, pp.1213-1225, 2014.

U. Rescher and T. Grewal, Highlight: Annexins in health and disease, Biol. Chem, vol.397, pp.947-948, 2016.

F. Lebouder, B. Lina, G. F. Rimmelzwaan, and B. Riteau, Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase, J. Gen. Virol, vol.11, pp.2753-2761, 2010.

Y. Ma, J. Sun, L. Gu, H. Bao, Y. Zhao et al., Annexin A2 (ANXA2) interacts with nonstructural protein 1 and promotes the replication of highly pathogenic H5N1 avian influenza virus, BMC Microbiol, vol.17, 0191.

R. T. Huang, B. Lichtenberg, and O. Rick, Involvement of annexin V in the entry of influenza viruses and role of phospholipids in infection, FEBS Lett, vol.392, pp.59-62, 1996.

A. Musiol, S. Gran, C. Ehrhardt, S. Ludwig, T. Grewal et al., Annexin A6-balanced late endosomal cholesterol controls influenza A replication and propagation, MBio, vol.4, pp.608-621, 2013.

H. Ma, F. Kien, M. Maniere, Y. Zhang, N. Lagarde et al., Human annexin A6 interacts with influenza a virus protein M2 and negatively modulates infection, J. Virol, vol.86, pp.1789-1801, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-00645399

A. Kuehnl, A. Musiol, C. A. Raabe, and U. Rescher, Emerging functions as host cell factors-An encyclopedia of annexin-pathogen interactions, Biol. Chem, vol.397, pp.949-959, 2016.

P. Backes, D. Quinkert, S. Reiss, M. Binder, M. Zayas et al., Role of annexin A2 in the production of infectious hepatitis C virus particles, J. Virol, vol.84, pp.5775-5789, 2010.

M. C. Derry, M. R. Sutherland, C. M. Restall, D. M. Waisman, and E. L. Pryzdial, Annexin 2-mediated enhancement of cytomegalovirus infection opposes inhibition by annexin 1 or annexin 5, J. Gen. Virol, vol.88, issue.1, pp.19-27, 2007.

E. Nobusawa and K. Sato, Comparison of the mutation rates of human influenza A and B viruses, J. Virol, vol.80, pp.3675-3678, 2006.

G. A. Poland, R. M. Jacobson, and I. G. Ovsyannikova, Influenza virus resistance to antiviral agents: A plea for rational use, Clin. Infect. Dis, vol.48, pp.1254-1256, 2009.

S. Ludwig, Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections, Biol. Chem, vol.392, pp.837-847, 2011.

O. Planz, Development of cellular signaling pathway inhibitors as new antivirals against influenza, Antivir. Res, vol.98, pp.457-468, 2013.

S. Ludwig, Targeting cell signalling pathways to fight the flu: Towards a paradigm change in anti-influenza therapy, J. Antimicrob. Chemother, vol.64, pp.1-4, 2009.

G. Scheuch, S. Canisius, K. Nocker, T. Hofmann, R. Naumann et al., Targeting intracellular signaling as an antiviral strategy: Aerosolized LASAG for the treatment of influenza in hospitalized patients, Emerg. Microbes Infect, 2018.

E. Haasbach, C. Muller, C. Ehrhardt, A. Schreiber, S. Pleschka et al., The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo, Antivir. Res, vol.142, pp.178-184, 2017.

P. J. Carter, Potent antibody therapeutics by design, Nat. Rev. Immunol, vol.6, pp.343-357, 2006.